Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023

Rhea-AI Summary

Exagen Inc. will release its financial results for Q3 2023 on November 13, 2023. The conference call to review the results will be hosted by the President and CEO, John Aballi, and the CFO, Kamal Adawi. Interested parties can access the call via dial-in or webcast. A replay of the call will be available until November 27, 2023.

SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended September 30, 2023, after the market close on Monday, November 13, 2023. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 4:30 PM ET (1:30 PM PT).

Interested parties may access the conference call by dialing (201) 389-0918 (U.S.) or (877) 407-0890 (international). Participants wishing to access the call via webcast should use the link posted on the Exagen investor relations website at investors.exagen.com.

A replay of the conference call will be available until Monday, November 27, 2023, at 11:59 PM ET (8:59 PM PT). Interested parties may access the replay of the conference call by dialing (201) 612-7415 (U.S.) or (877) 660-6853 (international) using passcode 13741926. Additionally, a recording of the webcast will be available using the link on the Exagen investor relations website approximately one hour after the call concludes.

About Exagen Inc.

Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.

For more information, please visit Exagen.com and follow @ExagenInc on Twitter.

CONTACTS:

Investor Relations
Exagen Inc.
Ryan Douglas
rdouglas@exagen.com
760.560.1525

Company
Exagen Inc.
Kamal Adawi, Chief Financial Officer
kadawi@exagen.com

FAQ

When will Exagen release its financial results for Q3 2023?

Exagen will release its financial results for Q3 2023 on November 13, 2023.

Who will host the conference call to review the results?

The conference call to review the results will be hosted by Exagen's President and CEO, John Aballi, and CFO, Kamal Adawi.

How can interested parties access the conference call?

Interested parties can access the conference call by dialing (201) 389-0918 (U.S.) or (877) 407-0890 (international). They can also access the call via webcast using the link posted on the Exagen investor relations website at investors.exagen.com.

How long will the replay of the conference call be available?

The replay of the conference call will be available until November 27, 2023.

How can interested parties access the replay of the conference call?

Interested parties can access the replay of the conference call by dialing (201) 612-7415 (U.S.) or (877) 660-6853 (international) using passcode 13741926. They can also access a recording of the webcast using the link on the Exagen investor relations website approximately one hour after the call concludes.